MYC and lymphoma: Finally, to mimic an in vivo scenario more closely, where only some cells possess a particular mutation, we examined whether Arrdc3KOEμ-Myc lymphoma cells had a competitive advantage over control Eμ-Myc lymphoma cells when grown in sub-lethal doses of these drugs over a longer period.